MTOR and neoplasm: Preclinical studies have demonstrated that abrogation of mTOR signalling leads to tumour growth inhibition due to the central involvement of the mTOR pathway in myriad cellular processes, including cell growth, cell survival, protein synthesis and angiogenesis.